Thermo Fisher elects former CVS Health CEO Karen S. Lynch to its board

THERMO FISHER SCIENTIFIC INC.

Board size increased to 12; Lynch elected effective February 19, 2025, term until 2025 annual meeting.
Lynch, former President and CEO of CVS Health, brings over 30 years of health care experience.
Anticipated to serve on Audit Committee following re-election at 2025 annual meeting.
Will receive standard non-employee director compensation and indemnification agreement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Karen S. Lynch

director

TMO · THERMO FISHER SCIENTIFIC INC.

Effective: 2025-02-19
Filed: February 19, 2025, 6:59 PM ET

increased its size to twelve members and elected Karen S. Lynch as a director of the Company, effective February 19, 2025, for a term expiring at the Company’s 2025 annual meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Karen S. Lynch was elected as director at THERMO FISHER SCIENTIFIC INC..

Action: elected
Role: director

Exact text from the filing

increased its size to twelve members and elected Karen S. Lynch as a director of the Company, effective February 19, 2025, for a term expiring at the Company’s 2025 annual meeting.

View on SEC.gov

THERMO FISHER SCIENTIFIC INC. filing history →

Source: SEC EDGAR

accession 0000097745-25-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.